Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
CALL
iShares S&P 500 Growth ETF
IVW
$77.6B
| $3.93M | ﹤0.01% |
65,100
-2,200
| -3% | -$146K |
|
|
ICNC
4152
DELISTED
Iconic Sports Acquisition Corp.
ICNC
| $3.93M | ﹤0.01% |
392,796
-3,013
| -0.8% | -$30.1K |
|
4153
Schwab US TIPS ETF
SCHP
$16.2B
| $3.93M | ﹤0.01% |
+140,714
| New | +$4.08M |
|
4154
Curtiss-Wright
CW
$25.8B
| $3.92M | ﹤0.01% |
29,711
+3,251
| +12% | +$462K |
|
4155
PUT
Middleby
MIDD
$5.33B
| $3.92M | ﹤0.01% |
31,300
-5,800
| -16% | -$837K |
|
|
BNAI
4156
Brand Engagement Network
BNAI
$108M
| $3.92M | ﹤0.01% |
40,021
-34
| -0.1% | -$3.33K |
|
|
TWOA
4157
DELISTED
two
TWOA
| $3.92M | ﹤0.01% |
401,166
+609
| +0.2% | +$5.95K |
|
4158
CALL
Wyndham Hotels & Resorts
WH
$5.46B
| $3.91M | ﹤0.01% |
59,500
+8,800
| +17% | +$693K |
|
4159
CALL
Gen Digital
GEN
$17B
| $3.9M | ﹤0.01% |
177,700
+130,200
| +274% | +$3.2M |
|
4160
PUT
Icon
ICLR
$12.6B
| $3.9M | ﹤0.01% |
18,000
+200
| +1% | +$44.8K |
|
|
4161
iShares S&P 500 Growth ETF
IVW
$77.6B
| $3.9M | ﹤0.01% |
64,573
+22,663
| +54% | +$1.5M |
|
4162
BRC Group Holdings
RILY
$299M
| $3.9M | ﹤0.01% |
92,213
+84,083
| +1,034% | +$4.41M |
|
|
CPAR
4163
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
| $3.89M | ﹤0.01% |
399,733
-235,190
| -37% | -$2.29M |
|
4164
PUT
Intellia Therapeutics
NTLA
$1.67B
| $3.89M | ﹤0.01% |
75,200
-13,800
| -16% | -$701K |
|
|
CHS
4165
DELISTED
Chicos FAS, Inc.
CHS
| $3.89M | ﹤0.01% |
782,744
+199,803
| +34% | +$1.01M |
|
4166
CALL
AbCellera Biologics
ABCL
$3.49B
| $3.89M | ﹤0.01% |
364,900
+169,100
| +86% | +$1.43M |
|
4167
Allison Transmission
ALSN
$10.4B
| $3.88M | ﹤0.01% |
100,950
-109,964
| -52% | -$4.2M |
|
|
WIRE
4168
DELISTED
Encore Wire Corp
WIRE
| $3.88M | ﹤0.01% |
37,341
+88
| +0.2% | +$10.4K |
|
|
FVAM
4169
DELISTED
5:01 Acquisition Corp
FVAM
| $3.88M | ﹤0.01% |
391,976
-11
| -0% | -$109 |
|
4170
Grupo Cibest SA
CIB
$22.8B
| $3.88M | ﹤0.01% |
125,794
+84,627
| +206% | +$3.33M |
|
4171
Pulmonx
LUNG
$104M
| $3.88M | ﹤0.01% |
263,471
+85,518
| +48% | +$1.76M |
|
4172
CALL
Philips
PHG
$26.7B
| $3.88M | ﹤0.01% |
210,217
-33,239
| -14% | -$716K |
|
4173
CALL
Fox Class A
FOXA
$29B
| $3.87M | ﹤0.01% |
120,400
+34,700
| +40% | +$1.22M |
|
4174
CALL
Schrodinger
SDGR
$1.32B
| $3.87M | ﹤0.01% |
146,600
+15,800
| +12% | +$424K |
|
4175
Maravai LifeSciences
MRVI
$849M
| $3.87M | ﹤0.01% |
136,209
-298,682
| -69% | -$9.46M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.